ישראל - עברית - Ministry of Health

k.s.kim international ltd - atorvastatin as calcium trihydrate; ezetimibe - טבליות מצופות פילם - ezetimibe 10 mg; atorvastatin as calcium trihydrate 20 mg - atorvastatin and ezetimibe

ישראל - עברית - Ministry of Health

k.s.kim international ltd - atorvastatin as calcium trihydrate; ezetimibe - טבליות מצופות פילם - ezetimibe 10 mg; atorvastatin as calcium trihydrate 40 mg - atorvastatin and ezetimibe

ישראל - עברית - Ministry of Health

k.s.kim international ltd - atorvastatin as calcium trihydrate; ezetimibe - טבליות מצופות פילם - ezetimibe 10 mg; atorvastatin as calcium trihydrate 80 mg - atorvastatin and ezetimibe

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - ezetimibe; rosuvastatin as calcium - טבליות מצופות פילם - ezetimibe 10 mg; rosuvastatin as calcium 10 mg - rosuvastatin and ezetimibe

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - ezetimibe; rosuvastatin as calcium - טבליות מצופות פילם - ezetimibe 10 mg; rosuvastatin as calcium 20 mg - rosuvastatin and ezetimibe

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - ezetimibe; rosuvastatin as calcium - טבליות מצופות פילם - ezetimibe 10 mg; rosuvastatin as calcium 40 mg - rosuvastatin and ezetimibe

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - ezetimibe; rosuvastatin as calcium - טבליות מצופות פילם - ezetimibe 10 mg; rosuvastatin as calcium 5 mg - rosuvastatin and ezetimibe

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - ezetimibe; simvastatin - טבליה - simvastatin 20 mg; ezetimibe 10 mg - simvastatin - simvastatin - hypercholesterolemia: inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. inegy contains ezetimibe and simvastatin. simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. homozygous familial hypercholesterolemia (hofh): inegy is indicated as adjunctive therapy to diet for use in patients with hofh.patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [ldl] apheresis).

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - ezetimibe; simvastatin - טבליה - simvastatin 40 mg; ezetimibe 10 mg - simvastatin - simvastatin - hypercholesterolemia: inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. inegy contains ezetimibe and simvastatin. simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. homozygous familial hypercholesterolemia (hofh): inegy is indicated as adjunctive therapy to diet for use in patients with hofh. patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [ldl] apheresis).

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - ezetimibe; simvastatin - טבליה - simvastatin 80 mg; ezetimibe 10 mg - simvastatin - simvastatin - hypercholesterolemia: inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. inegy contains ezetimibe and simvastatin. simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. homozygous familial hypercholesterolemia (hofh): inegy is indicated as adjunctive therapy to diet for use in patients with hofh. patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [ldl] apheresis).